Drug safety is a leading factor in determining how medicines are regulated – trumping consideration of their comparative benefits. But, rather than assess a medicine’s safety in isolation, its adverse effects should be considered in relation to its efficacy for particular patients.
LONDON – The harmful effects of medicines capture headlines worldwide. After all, horror stories about “killer drugs” are easy to sell. But, while drugs’ damaging effects are a legitimate cause for concern, they do not necessarily constitute a serious public-health issue, provided that they are outweighed by the benefits they confer.
Drugs with serious adverse safety profiles are used to treat potentially fatal conditions – including various forms of cancer, inflammatory arthritis, and HIV – because they ultimately help more than they hurt. Rather than assess a medicine’s safety in isolation, its adverse effects must be considered in relation to its efficacy. In other words, a benefit-risk balance must be struck.
But getting this message across to the public has proven to be difficult. Successful drug treatment and disease prevention can fail to capture the attention of readers or voters. Moreover, drug safety is a leading factor in determining how medicines are regulated.
To continue reading, register now.
As a registered user, you can enjoy more PS content every month – for free.
In the longer term, oil and gas prices look set to rise unless investment picks up sharply, which seems unlikely given current policy guidance. Giant waves of supply and demand shocks will likely continue to roil energy markets and the global economy.
predicts further waves of supply and demand shocks in global oil and gas markets.
The American public has been alarmed and aroused by the US Supreme Court's growing extremism. But voters need to recognize the Court's radical majority for what it is: part of a carefully laid plan to turn the US into a repressive regime.
fears that the radicalization of the US Supreme Court is part of a larger plan to create a repressive regime.
LONDON – The harmful effects of medicines capture headlines worldwide. After all, horror stories about “killer drugs” are easy to sell. But, while drugs’ damaging effects are a legitimate cause for concern, they do not necessarily constitute a serious public-health issue, provided that they are outweighed by the benefits they confer.
Drugs with serious adverse safety profiles are used to treat potentially fatal conditions – including various forms of cancer, inflammatory arthritis, and HIV – because they ultimately help more than they hurt. Rather than assess a medicine’s safety in isolation, its adverse effects must be considered in relation to its efficacy. In other words, a benefit-risk balance must be struck.
But getting this message across to the public has proven to be difficult. Successful drug treatment and disease prevention can fail to capture the attention of readers or voters. Moreover, drug safety is a leading factor in determining how medicines are regulated.
To continue reading, register now.
As a registered user, you can enjoy more PS content every month – for free.
Register
orSubscribe now for unlimited access to everything PS has to offer.
Already have an account? Log in